Record #5474
FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer
Original paper date
Mar 23, 2011
Original DOI
Country
Institution
Tumor Immunity and Tolerance Section, Laboratory of Molecular Immunoregulation and Laboratory of Experimental Immunology, Cancer and Inflammation Program, National Cancer Institute-Frederick (NCI-Frederick), Frederick, Maryland, USA · SAIC-Frederick Inc., Frederick, Maryland, USA. 4Breast and Prostate Cancer Unit, Laboratory of Human Carcinogenesis, NCI, Frederick, Maryland, USA · Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan
Open access
No
Article type
Notes from Retraction Watch
Stephanie Watkins responsible; JME 06/27/2017
Citation lifecycle
How this paper is being cited
Pre-retraction
47
Same day
0
Post-retraction
26
% post-retraction
35.6%
~11.4 citations/yr before retraction · ~2.3 citations/yr after
— citing papers
Who is still citing this work
Loading…